GlassScriptPhysician profile
Seyed A Ghodsi
NPI 1205803814
$136,550.06
in general payments reported to CMS, 2019-2025
34 companies · $11K in 2025
The $11K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $19K · 2021: $27K · 2022: $18K · 2023: $19K · 2024: $3,181 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $5,608 · Travel and Lodging: $4,955 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,000.00 |
| Food and Beverage | $5,608.10 |
| Travel and Lodging | $4,954.73 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $122,354.91 | 2019-2025 | |
| Abbott Laboratories | $5,363.07 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic USA, INC. | $4,291.96 | 2019-2020 | |
| Relievant Medsystems, INC. | $1,533.08 | 2019-2023 | Intracept |
| Globus Medical, INC. | $860.92 | 2019-2025 | Senza, Vyrsa V1, Instafill |
| Medtronic, INC. | $601.13 | 2022-2025 | Unid_pass, Intellis Adaptivestim, Infinity Occipitocervical Upper Thoracic System |
| Vertos Medical, INC. | $177.48 | 2023 | Mild Device Kit |
| Depuy Synthes Sales INC. | $145.37 | 2019-2023 | X-Pac, Symphony |
| Mallinckrodt Enterprises LLC | $144.46 | 2019 | |
| Zimmer Biomet Holdings, INC. | $133.75 | 2019-2021 | |
| Flowonix Medical Incorporated | $108.28 | 2019 | |
| Pfizer INC. | $87.10 | 2020-2021 | |
| Integra Lifesciences Corporation | $67.57 | 2019-2025 | Codman Hakim, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Insulet Corporation | $67.55 | 2020 | |
| Augmedics INC. | $57.40 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $54.96 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $53.68 | 2019-2020 | |
| Providence Medical Technology, INC. | $52.50 | 2025 | |
| Alphatec Spine, INC | $43.40 | 2023 | Invictus Mis |
| Intrinsic Therapeutics | $42.42 | 2022-2023 | Barricaid Acd (Annular Closure Device) |
| Arbor Pharmaceuticals, INC. | $40.30 | 2019-2020 | |
| Kuros Biosciences USA, INC | $33.67 | 2024 | Magnetos |
| Davol INC. | $33.40 | 2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $31.50 | 2019 | |
| Tersera Therapeutics LLC | $26.74 | 2024 | Prialt |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Smith+Nephew, INC. | $18.71 | 2024 | Pico 14 |
| Livanova USA, INC. | $17.94 | 2022 | |
| Zimvie INC. | $16.88 | 2024 | |
| Azurity Pharmaceuticals, INC. | $16.19 | 2022 | |
| Lemaitre Vascular, INC. | $14.58 | 2023 | Anastoclip Gc 8cm (Medium) |
| Baxter Healthcare | $14.38 | 2023 | Floseal |
| Allergan, INC. | $13.64 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seyed Ghodsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.